Contribone S 600 Tablets

Adult dose

For individuals aged 12 and over: 1 tablet once daily, after meals

This medicine should not be taken by individuals with excessive calcium in the blood, kidney disease, or those suffering from unexplained systemic inflammatory diseases. Additionally, individuals allergic to soybean oil, soy, peanuts, or who have hypersensitivity to any ingredient included in this medicine should avoid taking it. Infants under 3 months old, patients with kidney stones, and those with severe renal failure symptoms may also be at risk when taking this medicine. Since this medicine contains lactose, individuals with problems in lactose breakdown or a genetic disorder causing glucose-galactose malabsorption should not take it. Do not take this medicine concurrently with levodopa. Women undergoing medical treatment, pregnant or possibly pregnant women, nursing mothers, premature infants, or young children should consult a healthcare professional before taking this medication. Patients on heart medications known as cardiac glycosides or those with dyslipidemia, diabetic dyslipidemia, or pancreatitis should also consult a specialist before use. Patients at risk of fat overload should regularly check their blood fat levels when taking this medicine and adjust their dosage as necessary. If other lipid products are administered together, the dosage of other lipid agents should be reduced considering the amount of fat included in this medicine. If symptoms such as nausea, vomiting, diarrhea, oral inflammation, loss of appetite, abdominal bloating, constipation, low blood pressure, flushing of the face, irregular heartbeat, skin rash, itching, or swelling occur during administration, immediately discontinue use and consult a healthcare professional. Long-term high-dose administration of vitamin B6 may cause neurological abnormalities; caution is advised. High doses of vitamin B12 may lead to blood-related abnormal reactions; caution is needed. High-dose use may worsen peptic ulcers, lead to impaired glucose control, increased uric acid, or liver damage. Long-term use may increase blood calcium levels or cause stone formation, requiring regular checks. If overdosing occurs or symptoms do not improve after one month of use, one must consult a specialist. The prescribed dosage and administration must be strictly observed, and this medicine may change the color of urine to yellow, potentially affecting certain clinical test results. This medicine should be stored out of reach of children, away from direct sunlight, in a cool, dry place sealed tightly. Moreover, to prevent misuse and maintain quality, it is important not to transfer it to another container.

Serious side effects

• Hives
• swelling
• skin rash
• rash
• papular rash

Mild side effects

Nausea, vomiting, loose stools, diarrhea, stomatitis (oral inflammation), loss of appetite, abdominal bloating, constipation, low blood pressure, facial flushing, irregular heartbeat, skin rash, erythema, eczema, rashes, papular rashes, itching, swelling, edema, water retention, sensory neuropathy or neurological symptoms, hematological adverse reactions, exacerbation of peptic ulcers, impaired glucose tolerance, hyperuricemia, liver damage, hypercalcemia and lithiasis, and may cause urine to turn yellow

This medicine may be sensitive to air and moisture, so it should be stored in a sealed container. It is also important to store it at room temperature between 1°C and 30°C to maintain its effectiveness.

Appearance

Brown oval film-coated tablet

Package unit

60 tablets/bottle, 120 tablets/bottle [60 tablets/bottle × 2]